Test yourself: the 2023 CPD and Learning quiz Assess your knowledge on topics ranging from infectious diseases, to professional skills, to cardiology, in our end-of-year CPD and learning quiz.…
European regulator’s committee recommends new safety measures for medicines containing pseudoephedrine The European Medicines Agency's risk assessment committee has recommended that medicines containing pseudoephedrine should not be used in patients with severe or uncontrolled high blood pressure, or people with severe acute or chronic kidney disease or failure.…
PrEP highly effective in cutting HIV transmission but better access needed, study finds Results of the 'PrEP Impact' trial show that PrEP reduced the chances of someone getting HIV by around 87%.…
Community pharmacy staff asked for views on provision of PrEP as part of NIHR research project The University of Bristol is conducting research on the barriers community pharmacies must overcome if they are to provide HIV pre-exposure prophylaxis.…
Roadmap to provide PrEP via community pharmacies will be ready by ‘end of the year’, government says Health minister Neil O’Brien said the government’s HIV action plan implementation steering group was currently “working to develop a PrEP roadmap”.…
Webinar: COVID-19 antivirals — where are we now? A panel of experts discuss the use of antivirals for the treatment of COVID-19, with consideration for the current landscape and future variants in this webinar recording.… Supported content
How we treated more than 100 hepatitis C patients at pharmacist-led clinics in North Wales Prescribing pharmacist Elizabeth Hurry explains how her team developed an accelerated care pathway to test and treat “hard to reach” patients with hepatitis C.…
Government reverts to September start date for flu and COVID-19 vaccination programmes The vaccination programmes will now begin in September 2023, rather than October, owing to concerns over a new COVID-19 variant.…
Government launches ‘ambitious’ asymptomatic mpox transmission study Results of the PRIME study will be used to inform the public health outbreak response to mpox, including future vaccination and testing strategies.…
